Background: The presence of COVID-19 in the world has brought changes to our society. The research groups around the world started an analysis of how the SARS-CoV-2 virus interacts pathophysiologically with biological systems. Objectives: Quantify, based on the literature, the scientific production by Institution and country of origin, which related the damage of COVID-19 in the Central Nervous System (CNS). Design and setting: We conducted a literature review. It was use the databases of PubMed, LILACS (Latin American and Caribbean Literature on Health Sciences), SciElo and The Lancet. Results: 91 articles were included. The Institutions with the most publications were: University of California (United States), All India Institute Of Medical Sciences (India) and Qingdao University (China), with May 2020 being the period with the most publications. The most frequent symptoms caused by COVID-19 in the CNS were: Anosmia, Headache, Vomiting, Nausea and Hyposmia. Conclusions: United States, India and China were the countries with an expressive, even small, number of publications relating the effects of COVID-19 on the CNS. The largest number of publications in May 2020 shows that studies were rapidly developed shortly after the disease was raised to the level of a pandemic in March of the same year. The symptomatic effects of the disease show the primary involvement of the respiratory system with effects on the CNS.
Objectives: To investigate antinociceptive and anti-inflammatory activities of the keto-alcoholic extract of A. brasiliana leaves in a mice model of acute colitis. Methods: The experiments were performed in Swiss mice; the keto-alcoholic extract of A. brasiliana leaves was prepared and flavonoids were quantified. The antinociceptive/analgesic activity was evaluated by the writhing test. The keto-alcoholic extract of A. brasiliana, saline and Dipyrone monohydrate were tested. Acute colitis was induced by 7.5% (v/v) acetic acid intrarectally and the animals were treated, by gavage, with keto-alcoholic extract of A. brasiliana, saline and Mesalazine. After euthanasia, intestinal segments of the mice were analyzed by macroscopic index and quantification of colonic edema. The mechanical hyperalgesia test was performed after induction of acute colitis with acetic acid and treatment of the mice using the electronic Von Frey test. Hepatotoxicity of the keto-alcoholic extract of A. brasiliana was tested by plasma dosage of the aspartate transaminase (AST) and alanine transaminase (ALT) enzymes. Data were analyzed by ANOVA followed by Tukey post-test considering P < 0.05 as significant. Results: In vivo results indicate that mice treated with the keto-alcoholic extract of A. brasiliana leaves at 100 and 300 mg/kg (0.872 and 2.616 mg total flavonoids/kg) showed a significant decrease in the number of writhing compared to the negative control. Between the two concentrations that were shown to be effective, no significant difference was observed. The Von Frey test points that mice treated with A. brasiliana extract at 30 (0.2616 mg of total flavonoids/kg), 100 and 300 mg/kg showed greater hyperalgesia. Regarding colitis, the mice treated with keto-alcoholic extract of A. brasiliana leaves at 10, 30, 100 and 300 mg/kg showed no lesions or lower-grade lesions when compared to the untreated group. In the quantification of edema no significant difference was observed among any experimental group. Plasma AST and ALT values were within normal reference values indicating no liver damage by the extract. Conclusion: The keto-alcoholic extract of A. brasiliana shows antinociceptive/analgesic and anti-inflammatory activity in an acute colitis model in mice without causing hepatotoxicity in the mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.